EssilorLuxottica EL.PA
EssilorLuxottica is a Franco-Italian eyewear giant that designs, manufactures, and sells lenses and sunglasses, including iconic brands like Ray-Ban and Oakley, and is expanding into AI-powered smart glasses. EssilorLuxottica shows solid financial health (ND/EBITDA 2.29) and 12.30% earnings growth, but its valuation (P/E 27.44) and low ROE (6.72%) temper its appeal. The strong momentum in smart glasses is an opportunity, although regulatory risk on privacy is a factor to watch.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
EssilorLuxottica is a Franco-Italian eyewear giant that designs, manufactures, and sells lenses and sunglasses, including iconic brands like Ray-Ban and Oakley, and is expanding into AI-powered smart glasses. EssilorLuxottica shows solid financial health (ND/EBITDA 2.29) and 12.30% earnings growth, but its valuation (P/E 27.44) and low ROE (6.72%) temper its appeal. The strong momentum in smart glasses is an opportunity, although regulatory risk on privacy is a factor to watch.
Score by category
| Category | Score |
|---|---|
| Financial health | 5.6 |
| Quality / Moat | 5.5 |
| Valuation | 5.3 |
| Growth | 6.2 |
| Dividend | 6.3 |
| Momentum | 0.5 |
| Risk & Context | 7.0 |
OVERALL SCORE: 5.5/10
Context and risks
The smart glasses business, while promising, is subject to increasing regulatory scrutiny on data privacy, especially in the EU, its main market. This risk is not reflected in financial metrics.
News considered in the analysis
- Is Meta (META) Quietly Rewriting Its Hardware Strategy Through Muse-Powered Ray-Ban AI Glasses? — Refuerza la posición de EssilorLuxottica en el creciente mercado de gafas inteligentes, un motor de crecimiento potencial a largo plazo.
- EssilorLuxottica Société Anonyme (ENXTPA:EL) Following UBS Luxury Conference Is The Growth Story Mispriced — Un análisis de UBS sugiere que el mercado no está valorando completamente la historia de crecimiento de la compañía, lo que podría apoyar la valoración.
- Analysis-From smart glasses to AI pins, privacy fears challenge tech's next big bet — Las preocupaciones sobre la privacidad podrían frenar la adopción de gafas inteligentes, un segmento clave para el crecimiento futuro de la compañía.
- US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO — Noticia irrelevante sobre otra empresa del sector salud.
- Barron’s Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap — Noticia sobre un competidor (Cooper) sin impacto directo en EssilorLuxottica.
Verdict: Hold. The company has solid fundamentals and a growth story, but valuation is not a bargain and momentum is very negative (5th percentile in 52 weeks).
Main risk: The main risk is slow adoption or adverse regulation on smart glasses, which could fail to meet growth expectations and impact the company's valuation.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →